Alzheimer’s disease is a progressive neurological disorder that affects memory, thinking, and behavior. With millions of individuals and families impacted worldwide, finding effective and manageable treatments is a top priority. One such advancement in dementia care is the Rivastigmine Transdermal Patch — a convenient and reliable solution for patients and caregivers alike.
What is the Rivastigmine Patch?
The Rivastigmine Transdermal Patch is a medicated adhesive patch that delivers a steady dose of rivastigmine through the skin over 24 hours. It is commonly used in the management of mild to moderate Alzheimer’s disease, as well as Parkinson’s disease dementia. As a cholinesterase inhibitor, Rivastigmine helps improve communication between nerve cells by increasing levels of a chemical messenger in the brain.
Rivastigmine Patch Dosage
One of the most prescribed strengths is Rivastigmine 4.6mg/24h, which releases 4.6 mg of rivastigmine over a 24-hour period. This dosage is often used as an initial step before titrating to higher doses (like 9.5 mg/24h or 13.3 mg/24h), based on patient tolerance and clinical response.
The patch should be applied once daily to a clean, dry, hairless area of the skin (such as the upper back or chest), and should be rotated daily to avoid irritation.
Benefits of the Rivastigmine Patch
Steady Drug Delivery: Maintains consistent levels of medication in the body, reducing fluctuations and side effects.
Improved Tolerability: Lower risk of gastrointestinal side effects compared to oral forms.
Once-Daily Application: Enhances patient compliance, especially in elderly populations with memory challenges.
Non-Invasive: No need for pills or injections — ideal for those with difficulty swallowing.
HetRiva by Hetero Healthcare
HetRiva 9 Patch is Hetero Healthcare’s trusted formulation of Rivastigmine transdermal therapy. Manufactured with advanced patch technology, it ensures effective absorption and sustained delivery, making it a dependable choice for long-term Alzheimer's disease management.
Conclusion
Managing Alzheimer’s disease requires a blend of medical innovation and patient-centered care. The Rivastigmine Transdermal Patch — especially the Rivastigmine 4.6mg/24h dosage — offers a practical and effective option to support cognitive function and quality of life. Speak to your healthcare provider to see if this patch-based treatment is right for your loved one.